340B Ceiling Price, Civil Monetary Penalties Rule Delayed Until March 21

March 2, 2017

Inside Health Policy reported that The Health Resources and Services Administration (HRSA) announced that the effective date for the 340B Drug Pricing Program Ceiling Price and Manufacturer Civil Monetary Penalties final rule has been delayed until March 21, 2017. HRSA also announced that since this effective date falls in the middle of a quarter, enforcement of the requirements of the rule will begin April 1, 2017, the start of the next quarter.